MONTREAL and CHARLOTTE, N.C., March 1, 2022 /PRNewswire/ —  Milestone Pharmaceuticals Inc.  (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that members of management will present at the following

Related Posts